A detailed history of Israel Englander (Millennium Management LLC) transactions in Precigen, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 141,925 shares of PGEN stock, worth $127,732. This represents 0.0% of its overall portfolio holdings.

Number of Shares
141,925
Previous 1,370,451 89.64%
Holding current value
$127,732
Previous $1.99 Million 88.73%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.27 - $1.75 $1.56 Million - $2.15 Million
-1,228,526 Reduced 89.64%
141,925 $224,000
Q1 2024

May 15, 2024

SELL
$1.21 - $1.75 $1.79 Million - $2.58 Million
-1,475,460 Reduced 51.84%
1,370,451 $1.99 Million
Q4 2023

Feb 14, 2024

BUY
$0.89 - $1.41 $2.44 Million - $3.86 Million
2,739,944 Added 2585.66%
2,845,911 $3.81 Million
Q2 2023

Aug 14, 2023

SELL
$0.96 - $1.4 $155,908 - $227,367
-162,405 Reduced 60.51%
105,967 $121,000
Q1 2023

May 15, 2023

SELL
$0.88 - $2.19 $1.91 Million - $4.74 Million
-2,166,233 Reduced 88.98%
268,372 $284,000
Q4 2022

Feb 14, 2023

BUY
$1.27 - $2.26 $2.87 Million - $5.11 Million
2,259,629 Added 1291.39%
2,434,605 $3.7 Million
Q3 2022

Nov 14, 2022

SELL
$1.41 - $2.79 $3.74 Million - $7.39 Million
-2,649,195 Reduced 93.8%
174,976 $371,000
Q2 2022

Aug 15, 2022

SELL
$1.15 - $2.53 $2.43 Million - $5.34 Million
-2,109,264 Reduced 42.75%
2,824,171 $3.78 Million
Q1 2022

May 16, 2022

BUY
$1.91 - $3.98 $5.44 Million - $11.3 Million
2,849,987 Added 136.79%
4,933,435 $10.4 Million
Q4 2021

Feb 14, 2022

BUY
$3.53 - $5.5 $6.23 Million - $9.71 Million
1,764,940 Added 554.13%
2,083,448 $7.73 Million
Q3 2021

Nov 15, 2021

BUY
$4.99 - $6.55 $1.59 Million - $2.09 Million
318,508 New
318,508 $1.59 Million
Q2 2021

Aug 16, 2021

SELL
$6.24 - $8.22 $2.36 Million - $3.11 Million
-378,715 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$6.74 - $10.95 $2.55 Million - $4.15 Million
378,715 New
378,715 $2.61 Million
Q4 2020

Feb 16, 2021

SELL
$3.75 - $10.56 $410,463 - $1.16 Million
-109,457 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$3.5 - $6.2 $768,026 - $1.36 Million
-219,436 Reduced 66.72%
109,457 $383,000
Q2 2020

Aug 14, 2020

SELL
$2.16 - $5.46 $1.44 Million - $3.65 Million
-668,288 Reduced 67.02%
328,893 $1.64 Million
Q1 2020

May 14, 2020

BUY
$1.46 - $7.19 $1.46 Million - $7.17 Million
997,181 New
997,181 $3.39 Million

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $187M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.